The Pfizer Clinical Research Unit in New Haven is seeking healthy volunteers for a clinical trial of a study drug for type 2 diabetes and general weight management and blood sugar control. This study will look at the effects and metabolism of 2 oral forms of the study drug when taken without food.
Type 2 diabetes (T2D) is a chronic disease that occurs when a person’s body does not make or use insulin effectively to regulate blood sugar. Despite the availability of multiple treatments, approximately half of people diagnosed with T2D are not at their blood sugar goal. Harnessing our legacy and expertise in cardiovascular and metabolic diseases, Pfizer aims to identify and develop breakthrough treatments for people with this disease.
Read more about this study below and see how you can make a difference as a healthy volunteer.
Who may participate
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.